← Back to headlines
AMLX Stock Soars as Amylyx GLP-1 Drug Succeeds in Late-Stage Trial
Amylyx Pharmaceuticals' stock (AMLX) surged following the successful outcome of a late-stage trial for its GLP-1 drug.
18 Aug, 20:10 — 18 Aug, 20:10
Sources
Showing 1 of 1 sources
Related Stories
Dutch Central Bank Shifts 86 Tonnes of Gold to London for Crisis Readiness
22m ago
Trump Comments on US-Iran Military Strikes and Strait of Hormuz Control
42m ago
Uber Launches London’s First Robotaxi Service Amid Global Restructuring
54m ago
South Korean Utility Proposes Multi-Billion Dollar Advance Power Payment from Samsung
58m ago